Home › Companies › IVERIC BIO INC. › 2023-2024
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and IVERIC BIO INC.’s Form 8-K, filed July 6, 2023 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of July 6, 2023: 3 items on IVERIC BIO INC.’s Form 8-K, filed July 6, 2023: 3 passed (calculated).
Notable dissent: 1 other board item (26.8% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Proxy season: 2023-2024
Explore IVERIC BIO INC. in the interactive database Compare manager voting policies
These tallies are IVERIC BIO INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed July 6, 2023 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| 1. The Merger Proposal | 109,590,295 | 94,590 | 458,429 | -- | 0 | 99.9% | Passed (calculated) | — |
| 2. The Compensation Proposal | 79,668,097 | 29,241,961 | 1,233,256 | -- | 0 | 73% | Passed (calculated) | — |
| 3. The Adjournment Proposal | 101,361,184 | 8,291,820 | 490,310 | -- | 0 | 92% | Passed (calculated) | — |
Source: IVERIC BIO INC., Form 8-K, filed with the SEC on July 6, 2023 — read the filing on EDGAR.
See voting trends for Health Care companies, 2023-2024: shareholder support by sector and by company size.
266 asset managers disclosed a vote on at least one IVERIC BIO INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of IVERIC BIO INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 4 wordings of this item as funds reported it.
100% of fund votes cast · no official result
Description as filed by funds: To adopt the Agreement and Plan of Merger (the "Merger Agreement"), dated April 28, 2023, by and among IVERIC bio, Inc. ("IVERIC"), Astellas US Holding, Inc. ("Parent"), Berry Merger Sub, Inc., a wholly owned subsidiary of Parent ("Merger Sub"), and Solely as provided by Section 8.10(b) of the Merger Agreement, Astellas Pharma Inc., pursuant to which Merger Sub will merge with and into IVERIC, and IVERIC will become a wholly owned subsidiary of Parent (the "Merger").
The 91 asset managers below reported 42,485,811 for, 450,000 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 13,237,271 | 0 | 0 | 0 | For |
| BlackRock | 5,736,791 | 0 | 0 | 0 | For |
| Investment Managers Series Trust II | 3,661,747 | 0 | 0 | 0 | For |
| State Street | 2,778,367 | 0 | 0 | 0 | For |
| Fidelity | 2,621,322 | 0 | 0 | 0 | For |
| Invesco | 2,010,048 | 0 | 0 | 0 | For |
| MERGER FUND | 1,302,908 | 0 | 0 | 0 | For |
| TIAA | 1,027,249 | 0 | 0 | 0 | For |
| Dimensional | 1,003,201 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 999,058 | 0 | 0 | 0 | For |
| Charles Schwab | 981,748 | 0 | 0 | 0 | For |
| AllianceBernstein | 555,222 | 0 | 0 | 0 | For |
| Federated Hermes | 0 | 0 | 450,000 | 0 | Abstain |
| Equitable | 447,534 | 0 | 0 | 0 | For |
| American Century | 421,389 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 383,600 | 0 | 0 | 0 | For |
| Principal | 336,989 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 315,636 | 0 | 0 | 0 | For |
| TimesSquare Capital Management, LLC | 263,400 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 232,692 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 232,094 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 227,111 | 0 | 0 | 0 | For |
| Jackson National | 226,599 | 0 | 0 | 0 | For |
| Putnam | 203,341 | 0 | 0 | 0 | For |
| ARBITRAGE FUNDS | 180,032 | 0 | 0 | 0 | For |
Showing the 25 largest of 91 asset managers. All 91 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
86% of fund votes cast · no official result
Description as filed by funds: To approve the adjournment of the special meeting to a later date or dates if necessary or appropriate to solicit additional proxies if there are insufficient votes to adopt the Merger Agreement at the time of the special meeting.
The 89 asset managers below reported 34,238,639 for, 5,453,627 against, 20,487 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 13,237,271 | 0 | 0 | 0 | For |
| BlackRock | 5,736,791 | 0 | 0 | 0 | For |
| State Street | 0 | 2,778,367 | 0 | 0 | Against |
| Fidelity | 99,436 | 2,521,886 | 0 | 0 | Against |
| Invesco | 2,010,048 | 0 | 0 | 0 | For |
| MERGER FUND | 1,302,908 | 0 | 0 | 0 | For |
| TIAA | 1,027,249 | 0 | 0 | 0 | For |
| Dimensional | 1,003,201 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 999,058 | 0 | 0 | 0 | For |
| Charles Schwab | 981,748 | 0 | 0 | 0 | For |
| Investment Managers Series Trust II | 569,842 | 0 | 0 | 0 | For |
| AllianceBernstein | 555,222 | 0 | 0 | 0 | For |
| Federated Hermes | 450,000 | 0 | 0 | 0 | For |
| Equitable | 447,534 | 0 | 0 | 0 | For |
| American Century | 421,389 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 383,600 | 0 | 0 | 0 | For |
| Principal | 336,989 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 315,636 | 0 | 0 | 0 | For |
| TimesSquare Capital Management, LLC | 263,400 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 232,692 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 232,094 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 227,111 | 0 | 0 | 0 | For |
| Jackson National | 226,599 | 0 | 0 | 0 | For |
| Putnam | 203,341 | 0 | 0 | 0 | For |
| ARBITRAGE FUNDS | 180,032 | 0 | 0 | 0 | For |
Showing the 25 largest of 89 asset managers. All 89 are in the interactive database (link above).
Combines 8 wordings of this item as funds reported it.
68% Fund and manager reports combined; may count the same shares twice · no official result
Description as filed by funds: To approve, by non-binding, advisory vote, compensation that may be paid or become payable by IVERIC to its named executive officers in connection with the Merger.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 0 | 13,237,271 | 0 | 0 | Against |
| BlackRock | 5,736,791 | 0 | 0 | 0 | For |
| State Street | 2,778,367 | 0 | 0 | 0 | For |
| Fidelity | 2,610,750 | 10,572 | 0 | 0 | For |
| Invesco | 2,010,048 | 0 | 0 | 0 | For |
| MERGER FUND | 1,302,908 | 0 | 0 | 0 | For |
| TIAA | 0 | 1,027,249 | 0 | 0 | Against |
| Dimensional | 0 | 1,003,201 | 0 | 0 | Against |
| JANUS INVESTMENT FUND | 999,058 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 981,748 | 0 | 0 | Against |
| Investment Managers Series Trust II | 559,742 | 10,100 | 0 | 0 | For |
| AllianceBernstein | 0 | 555,222 | 0 | 0 | Against |
| Federated Hermes | 0 | 0 | 450,000 | 0 | Abstain |
| Equitable | 236,810 | 210,724 | 0 | 0 | Mixed |
| American Century | 421,389 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 0 | 383,600 | 0 | 0 | Against |
| Principal | 241,358 | 95,631 | 0 | 0 | Mixed |
| FINANCIAL INVESTORS TRUST | 315,636 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 232,692 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 232,094 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 227,111 | 0 | 0 | 0 | For |
| Jackson National | 203,636 | 22,963 | 0 | 0 | Mixed |
| Putnam | 0 | 203,341 | 0 | 0 | Against |
| ARBITRAGE FUNDS | 180,032 | 0 | 0 | 0 | For |
| Lincoln Financial | 163,920 | 12,000 | 0 | 0 | Mixed |
Fund voting reports, all 88 managers: 20,512,188 for, 18,367,910 against, 569,255 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Avoro Capital Advisors LLC | 8,500,000 | 0 | 0 | 0 | For |
| Man Group plc | 0 | 7,068,940 | 0 | 0 | Against |
| State Street | 5,188,668 | 0 | 0 | 0 | For |
| BlackRock | 3,786,342 | 51,108 | 0 | 0 | For |
| UBS | 2,893,531 | 344,120 | 0 | 0 | Mixed |
| FARALLON CAPITAL MANAGEMENT LLC | 3,134,799 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 2,620,632 | 0 | 0 | 0 | For |
| TIG Advisors, LLC | 2,167,886 | 0 | 0 | 0 | For |
| Segantii Capital Management Ltd | 2,085,000 | 0 | 0 | 0 | For |
| AllianceBernstein | 0 | 2,034,996 | 0 | 0 | Against |
| Invesco | 2,006,708 | 0 | 0 | 0 | For |
| Meeder Advisory Services, Inc. | 2,000,000 | 0 | 0 | 0 | For |
| BRAIDWELL LP | 1,802,799 | 0 | 0 | 0 | For |
| BALYASNY ASSET MANAGEMENT L.P. | 0 | 1,583,715 | 0 | 0 | Against |
| Deep Track Capital, LP | 1,231,826 | 0 | 0 | 0 | For |
| MPM BioImpact LLC | 1,214,662 | 0 | 0 | 0 | For |
| Nuveen | 1,647 | 1,191,930 | 0 | 0 | Against |
| Soleus Capital Management, L.P. | 1,140,943 | 0 | 14,100 | 0 | For |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 0 | 1,153,000 | 0 | 0 | Against |
| Redmile Group, LLC | 0 | 1,111,111 | 0 | 0 | Against |
| Sand Grove Capital Management LLP | 1,088,094 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 997,771 | 0 | 0 | Against |
| Magnetar Financial LLC | 943,756 | 0 | 0 | 0 | For |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 832,113 | 0 | 0 | 0 | For |
| ARMISTICE CAPITAL, LLC | 825,306 | 0 | 0 | 0 | For |
Institutional-manager reports, all 190 managers: 58,567,158 for, 19,043,139 against, 665,790 abstained, 600 not voted. Showing the 25 largest; every one is in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
89% of fund votes cast · no official result
The 4 asset managers below reported 1,451,365 for, 182,622 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,450,000 | 0 | 0 | 0 | For |
| JPMorgan | 0 | 182,622 | 0 | 0 | Against |
| Desjardins Global Asset Management Inc. | 1,365 | 0 | 0 | 0 | For |
| Taconic Capital Advisors LP | 0 | 0 | 0 | 0 | -- |
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 137,249,579 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 9.64% |
| 2 | BlackRock | 4.18% |
| 3 | State Street | 2.02% |
| 4 | Fidelity | 1.91% |
| 5 | Invesco | 1.46% |
| 6 | MERGER FUND | 0.95% |
| 7 | TIAA | 0.75% |
| 8 | Dimensional | 0.73% |
| 9 | JANUS INVESTMENT FUND | 0.73% |
| 10 | Charles Schwab | 0.72% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Avoro Capital Advisors LLC | 6.19% |
| 2 | Man Group plc | 5.15% |
| 3 | State Street | 3.78% |
| 4 | BlackRock | 2.80% |
| 5 | UBS | 2.36% |
| 6 | FARALLON CAPITAL MANAGEMENT LLC | 2.28% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 1.91% |
| 8 | TIG Advisors, LLC | 1.58% |
| 9 | Segantii Capital Management Ltd | 1.52% |
| 10 | AllianceBernstein | 1.48% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| Norges Bank | 268,586 | 0.20% | Form 13F, quarter ended March 31, 2024 |
Percentages above are of 137,249,579 shares outstanding, as reported by IVERIC BIO INC. on its Form 10-Q dated March 31, 2023 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At IVERIC BIO INC.'s shareholder meeting held July 6, 2023, in the 2023-2024 proxy season, 266 asset managers reported votes on at least one item in their SEC Form N-PX filings, covering 1,113 separate fund positions. Their filings are grouped here into 4 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. IVERIC BIO INC.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — To approve, by non-binding, advisory vote, compensation that may be paid or become payable by… — the reporting funds and managers cast 68% of the shares they voted in favour (FOR divided by FOR plus AGAINST plus WITHHELD; abstained and unvoted shares are excluded because neither took a side). Fund and manager reports are combined in it and may count the same shares twice: it adds fund reports to institutional-manager reports, which can cover the same shares. It is not the company's certified result.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from IVERIC BIO INC.’s 10-Q dated March 31, 2023. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
IVERIC BIO INC. proxy season coverage: 2023-2024 (this page).
Proxy Votes Now, “IVERIC BIO INC. 2023 Special Meeting (2023-2024 season): Vote Results”, https://proxyvotesnow.com/company/iveric-bio-inc/2024 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.